Cancer Stem‐like Cells‐Oriented Surface Self‐Assembly to Conquer Radioresistance

Qian Wang,Hongmei Cao,Xiaoxue Hou,Dianyu Wang,Zhilong Wang,Yue Shang,Shuqin Zhang,Jinjian Liu,Chunhua Ren,Jianfeng Liu

DOI: https://doi.org/10.1002/adma.202302916

IF: 29.4

2023-06-09

Advanced Materials

Abstract:Cancer stem‐like cells (CSCs), capable of indefinite self‐renewal and differentiation, are considered to be the root cause of tumor radiotherapy (RT) resistance. However, the CSCs‐targeted therapy still remains to be a great challenge because they are commonly located in the deep tumor making drugs hard to approach, and their hypoxic and acidic niche can further aggravate radioresistance. Herein, based on our finding that hypoxic CSCs highly express carbonic anhydrase IX (CAIX) on the cell membrane, a CAIX‐targeted induced in situ self‐assembly system on the surface of CSC is reported to overcome hypoxic CSC‐mediated radioresistance. Via the sequential processes of "monomer release‐target accumulation‐surface self‐assembly," the constructed peptide‐based drug delivery system (CA‐Pt) exhibits the advantages of deep penetration, amplified CAIX inhibition, and enhanced cellular uptake, which greatly relieves the hypoxic and acidic microenvironment to promote the hypoxic CSC differentiation and combines with platinum to boost the RT‐inducing DNA damage. In both lung cancer tumor mouse and zebrafish embryo models, CA‐Pt treatment can effectively assist RT in suppressing tumor growth and preventing tumor invasion and metastasis. This study used a surface‐induced self‐assembly strategy to differentiate hypoxic CSCs, which may provide a universal treatment strategy for overcoming tumor radioresistance. This article is protected by copyright. All rights reserved

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the radioresistance problem caused by cancer stem cells (CSCs) in tumor radiotherapy (RT). Specifically, CSCs are considered to be the fundamental cause of tumor radioresistance due to their unlimited self - renewal and differentiation capabilities. However, treatment methods for CSCs still face great challenges because these cells are usually located deep within the tumor, making it difficult for drugs to reach them, and their hypoxic and acidic microenvironments further exacerbate radioresistance.

To overcome this problem, based on the discovery that CSCs in a hypoxic state highly express carbonic anhydrase IX (CAIX) on the cell membrane, researchers developed an inducible surface self - assembly system targeting CAIX, aiming to overcome the radioresistance mediated by hypoxic CSCs through this system. This system constructs a peptide - based drug delivery system (CA - Pt) through the sequential process of "monomer release - targeted accumulation - surface self - assembly". This system has the advantages of deep penetration, enhanced CAIX inhibition, and increased cell uptake rate, etc. It can significantly improve the hypoxic and acidic microenvironments, promote the differentiation of hypoxic CSCs, and combine platinum - based drugs to enhance radiotherapy - induced DNA damage. The research results show that this strategy effectively assists radiotherapy in lung cancer tumor mouse and zebrafish embryo models, inhibits tumor growth, and prevents tumor invasion and metastasis, providing a general treatment strategy for overcoming tumor radioresistance.